Esther Oomen-de Hoop

19PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples theory of change models for healthCancer diagnosisMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 26, 2025
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma.

Ruben Malmberg, Maaike M Hofman, Fatima Ashad

|Sep 04, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Elisabeth M Jongbloed, Noor Wortelboer, Vanja de Weerd

|Apr 30, 2025
Improving Shared Decision-Making in Early Phase Clinical Trials and Palliative Care: A Prospective Study on the Impact of an Online Value Clarification Tool Intervention.

Liza G G van Lent, Julia C M van Weert, Maja J A de Jonge

|Jun 07, 2024
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch Study.

Ruben Malmberg, Leni van Doorn, Juul M Cox

|Nov 16, 2023
Quality of cancer treatment care before and after a palliative care pathway: bereaved relatives' perspectives.

Annemieke van der Padt-Pruijsten, Maria Bl Leys, Esther Oomen-de Hoop

|Sep 30, 2023
Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.

Marjolijn M Ladan, Titia G Meijer, Nicole S Verkaik

Pageof 4

Frequent Collaborators

9 joint publications

Ron H J Mathijssen

4 joint publications

Carin C D van der Rijt

3 joint publications

Astrid A M van der Veldt

2 joint publications

Jorie Versmissen